Immunotoxicity Profiles & Nonclinical Research Strategies for T-Cell Engager Therapeutics

12:30 pm - Thursday 25th June 2026

  • Mechanisms of Action and Immunotoxicity Profiles of T-Cell Engager Therapeutics
  • Multidimensional Immunotoxicity Assessment Strategies

Speakers:

BD&PM
WestChina-Frontier PharmaTech Co., Ltd.